Mao Q - Search Results

1

Breast cancer resistance protein 1 limits fetal distribution of nitrofurantoin in the pregnant mouse.

Zhang Y, Wang H, Unadkat JD, Mao Q. Zhang Y, et al. Among authors: mao q. Drug Metab Dispos. 2007 Dec;35(12):2154-8. doi: 10.1124/dmd.107.018044. Epub 2007 Sep 4. Drug Metab Dispos. 2007. PMID: 17785426

2

HIV protease inhibitors are inhibitors but not substrates of the human breast cancer resistance protein (BCRP/ABCG2).

Gupta A, Zhang Y, Unadkat JD, Mao Q. Gupta A, et al. Among authors: mao q. J Pharmacol Exp Ther. 2004 Jul;310(1):334-41. doi: 10.1124/jpet.104.065342. Epub 2004 Mar 8. J Pharmacol Exp Ther. 2004. PMID: 15007102

3

Functional expression of the human breast cancer resistance protein in Pichia pastoris.

Mao Q, Conseil G, Gupta A, Cole SP, Unadkat JD. Mao Q, et al. Biochem Biophys Res Commun. 2004 Jul 30;320(3):730-7. doi: 10.1016/j.bbrc.2004.06.012. Biochem Biophys Res Commun. 2004. PMID: 15240109

4

Functional analysis of the human variants of breast cancer resistance protein: I206L, N590Y, and D620N.

Vethanayagam RR, Wang H, Gupta A, Zhang Y, Lewis F, Unadkat JD, Mao Q. Vethanayagam RR, et al. Among authors: mao q. Drug Metab Dispos. 2005 Jun;33(6):697-705. doi: 10.1124/dmd.105.003657. Epub 2005 Mar 2. Drug Metab Dispos. 2005. PMID: 15743976

5

Role of the breast cancer resistance protein (ABCG2) in drug transport.

Mao Q, Unadkat JD. Mao Q, et al. AAPS J. 2005 May 11;7(1):E118-33. doi: 10.1208/aapsj070112. AAPS J. 2005. PMID: 16146333 Free PMC article.

6

BCRP transports dipyridamole and is inhibited by calcium channel blockers.

Zhang Y, Gupta A, Wang H, Zhou L, Vethanayagam RR, Unadkat JD, Mao Q. Zhang Y, et al. Among authors: mao q. Pharm Res. 2005 Dec;22(12):2023-34. doi: 10.1007/s11095-005-8384-4. Epub 2005 Nov 1. Pharm Res. 2005. PMID: 16247709

7

Regulation of BCRP/ABCG2 expression by progesterone and 17beta-estradiol in human placental BeWo cells.

Wang H, Zhou L, Gupta A, Vethanayagam RR, Zhang Y, Unadkat JD, Mao Q. Wang H, et al. Among authors: mao q. Am J Physiol Endocrinol Metab. 2006 May;290(5):E798-807. doi: 10.1152/ajpendo.00397.2005. Epub 2005 Dec 13. Am J Physiol Endocrinol Metab. 2006. PMID: 16352672 Free article.

8

Cyclosporin A, tacrolimus and sirolimus are potent inhibitors of the human breast cancer resistance protein (ABCG2) and reverse resistance to mitoxantrone and topotecan.

Gupta A, Dai Y, Vethanayagam RR, Hebert MF, Thummel KE, Unadkat JD, Ross DD, Mao Q. Gupta A, et al. Among authors: mao q. Cancer Chemother Pharmacol. 2006 Sep;58(3):374-83. doi: 10.1007/s00280-005-0173-6. Epub 2006 Jan 11. Cancer Chemother Pharmacol. 2006. PMID: 16404634

9

Expression of the breast cancer resistance protein (Bcrp1/Abcg2) in tissues from pregnant mice: effects of pregnancy and correlations with nuclear receptors.

Wang H, Wu X, Hudkins K, Mikheev A, Zhang H, Gupta A, Unadkat JD, Mao Q. Wang H, et al. Among authors: mao q. Am J Physiol Endocrinol Metab. 2006 Dec;291(6):E1295-304. doi: 10.1152/ajpendo.00193.2006. Am J Physiol Endocrinol Metab. 2006. PMID: 17082346 Free article.

10

Interactions of azole antifungal agents with the human breast cancer resistance protein (BCRP).

Gupta A, Unadkat JD, Mao Q. Gupta A, et al. Among authors: mao q. J Pharm Sci. 2007 Dec;96(12):3226-35. doi: 10.1002/jps.20963. J Pharm Sci. 2007. PMID: 17518356

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,225 results

Search Page

Filters